Breaking News Instant updates and real-time market news.

ADI

Analog Devices

$72.89

3.07 (4.40%)

, CCL

Carnival

$51.93

0.16 (0.31%)

10:08
11/23/16
11/23
10:08
11/23/16
10:08

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Analog Devices (ADI) upgraded to Buy from Neutral at BofA Merrill Lynch, with analyst Vivek Arya saying Analog's solid fourth quarter alleviates prior concerns regarding sales growth, Apple/consumer exposure, and Linear Technology (LLTC) accretion. 2. Carnival (CCL) upgraded to Outperform from Market Perform at Bernstein, with analyst David Beckel saying the company's results and forward trends have shown "remarkable stability." 3. Autoliv (ALV) upgraded to Neutral from Sell at Goldman with the firm citing valuation. 4. Bank of Montreal (BMO) upgraded to Neutral from Underperform at Credit Suisse with analyst Nick Stogdill citing a moderation in its premium valuation and leverage to rising U.S. interest rates. 5. EdR (EDR) upgraded to Buy from Neutral at BofA Merrill Lynch, with analyst Jeffrey Spector saying EdR has a strong balance sheet and growth, with a low risk development pipeline. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ADI

Analog Devices

$72.89

3.07 (4.40%)

CCL

Carnival

$51.93

0.16 (0.31%)

ALV

Autoliv

$100.99

-0.82 (-0.81%)

BMO

Bank of Montreal

$66.00

0.29 (0.44%)

EDR

EdR

$39.91

-0.15 (-0.37%)

  • 28

    Nov

ADI Analog Devices
$72.89

3.07 (4.40%)

11/23/16
BOFA
11/23/16
UPGRADE
BOFA
Buy
Analog Devices upgraded to Buy from Neutral at BofA/Merrill
11/23/16
11/23/16
UPGRADE
Target $85

Buy
Analog Devices upgraded to Buy on sales growth, accretion at BofA/Merrill
As previously reported, BofA/Merrill upgraded Analog Devices (ADI) to Buy from Neutral and raised its price target to $85 from $70. Analyst Vivek Arya said Analog's solid Q4 alleviates prior concerns regarding sales growth, Apple/consumer exposure, and Linear Technology (LLTC) accretion. Arya believes the Linear acquisition will create a powerful, diversified, and profitable vendor and is forecasting $5+ in FY18 free cash flow.
11/22/16
OPCO
11/22/16
NO CHANGE
Target $85
OPCO
Outperform
Analog Devices price target raised to $85 from $80 at Oppenheimer
Oppenheimer analyst Rick Schafer said Analog Devices' better than expected earnings and guidance show the company is executing at a high level and noted that its Linear Technology acquisition is on track to close in Q2. The analyst raised his price target on the stock to $85 from $80 and keeps an Outperform rating on Analog Devices shares.
11/16/16
MSCO
11/16/16
NO CHANGE
Target $78
MSCO
Overweight
Morgan Stanley positive on Analog Devices ahead of earnings and into 2017
Morgan Stanley analyst Craig Hettenbach said Analog Devices (ADI) is one of his top Overweight picks and sees upside to earnings for the next 2 quarters given strength in broad-based markets and strong opex controls. The analyst expects October quarterly earnings of 90c and $942M, in line with consensus, to prove to be conservative and sees meaningful accretion from the Linear Technology (LLTC) deal adding 84c to 2018 earnings and believes cost savings of $150M will prove to be too low.
CCL Carnival
$51.93

0.16 (0.31%)

11/23/16
BERN
11/23/16
UPGRADE
BERN
Outperform
Carnival upgraded on results, initiatives at Bernstein
As noted earlier, Bernstein upgraded Carnival to Outperform from Market Perform. Analyst David Beckel says that the company's results and forward trends have shown "remarkable stability." He thinks that its initiatives will cause its demand to increase and boost its yields. Target to $68 from $52.
10/27/16
JPMS
10/27/16
DOWNGRADE
Target $73
JPMS
Neutral
Royal Caribbean downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Joseph Greff downgraded Royal Caribbean (RCL) to Neutral saying he does not see a "meaningful fundamental turn" in net yields and pricing for the cruise lines. The analyst lowered his price target for the shares to $73 from $96. Greff this morning also downgraded Norwegian Cruise Line (NCLH) to Neutral and kept a Neutral rating on Carnival (CCL) with a reduced price target of $46.
11/22/16
BERN
11/22/16
UPGRADE
BERN
Outperform
Carnival upgraded to Outperform from Market Perform at Bernstein
11/01/16
11/01/16
NO CHANGE

Royal Caribbean, cruise sector poised to outperform, says Wells Fargo
After Royal Caribbean (RCL) reaffirmed its 2016 guidance and 2017 targets, Wells Fargo thinks that investors are beginning to regain confidence in the cruise sector, The firm expects the sector to outperform through at least early 2017, and it keeps an Outperform rating on Royal Caribbean. Other companies in the sector include Carnival (CCL) and Norwegian Cruise Line (NCLH).
ALV Autoliv
$100.99

-0.82 (-0.81%)

07/25/16
BARD
07/25/16
NO CHANGE
Target $131
BARD
Outperform
Autoliv weakness a buying opportunity, says Baird
Baird said the weakness in Autoliv created an attractive entry point for long-term investors. The firm remains buyers of the shares as they believe the near-term outlook was clouded by its Q2 miss and lower guidance. Baird expects investors to return to the stock given the company's elevated spending levels to support long-term organic growth. Baird reiterated its Outperform rating and lowered its price target to $131 from $137 on Autoliv shares.
11/23/16
GSCO
11/23/16
UPGRADE
Target $95
GSCO
Neutral
Autoliv upgraded to Neutral from Sell at Goldman
Goldman upgraded Autoliv to Neutral citing valuation and lowered its price target to $95 from $101.
10/28/16
BARD
10/28/16
DOWNGRADE
BARD
Neutral
Autoliv downgraded to Neutral from Outperform at Baird
10/28/16
BARD
10/28/16
DOWNGRADE
Target $104
BARD
Neutral
Autoliv downgraded to Neutral at Baird
As reported previously, Baird analyst David Leiker downgraded Autoliv to Neutral from Outperform as organic sales and earnings growth slow on legacy roll-offs in the active safety business. Leiker lowered his price target to $104 from $129 on Autoliv shares.
BMO Bank of Montreal
$66.00

0.29 (0.44%)

11/23/16
FBCO
11/23/16
UPGRADE
FBCO
Neutral
Bank of Montreal upgraded to Neutral from Underperform at Credit Suisse
Credit Suisse analyst Nick Stogdill upgraded Bank of Montreal to Neutral due to a moderation in its premium valuation and leverage to rising U.S. interest rates.
11/01/16
BOFA
11/01/16
INITIATION
Target $66
BOFA
Neutral
Bank of Montreal reinstated with a Neutral at BofA/Merrill
BofA/Merrill analyst Ebrahim Poonawala reinstated Bank of Montreal with a Neutral and a $66 price target.
09/21/16
DUND
09/21/16
INITIATION
DUND
Neutral
Bank of Montreal initiated with a Neutral at Dundee
10/04/16
FBCO
10/04/16
DOWNGRADE
FBCO
Underperform
Bank of Montreal downgraded to Underperform from Neutral at Credit Suisse
EDR EdR
$39.91

-0.15 (-0.37%)

11/17/16
HDLY
11/17/16
UPGRADE
HDLY
Neutral
EdR upgraded to Neutral from Underperform at Hilliard Lyons
11/23/16
BOFA
11/23/16
UPGRADE
BOFA
Buy
EdR upgraded to Buy on growth at BofA/Merrill
As previously reported, BofA/Merrill upgraded EdR from Neutral and maintained its $46 price target. Analyst Jeffrey Spector said EdR has a strong balance sheet and growth, with a low risk development pipeline.
11/23/16
BOFA
11/23/16
UPGRADE
BOFA
Buy
EdR upgraded to Buy from Neutral at BofA/Merrill
10/31/16
10/31/16
NO CHANGE

EdR reports Q3 Core FFO 4c, may not compare to consensus 28c
Reports Q3 revenue $66.23M, consensus $62.09M.

TODAY'S FREE FLY STORIES

JKHY

Jack Henry

$125.32

0.17 (0.14%)

17:12
01/22/18
01/22
17:12
01/22/18
17:12
Initiation
Jack Henry initiated  »

Jack Henry initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIZ

Assurant

$94.03

-0.05 (-0.05%)

17:10
01/22/18
01/22
17:10
01/22/18
17:10
Syndicate
Breaking Syndicate news story on Assurant »

Assurant files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

FSLR

First Solar

$68.96

-1.07 (-1.53%)

17:08
01/22/18
01/22
17:08
01/22/18
17:08
Technical Analysis
Technical Take: First Solar spikes after tariff decision »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRO

Brown & Brown

$52.25

-0.25 (-0.48%)

17:05
01/22/18
01/22
17:05
01/22/18
17:05
Earnings
Brown & Brown reports Q4 EPS 47c, consensus 42c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

EAT

Brinker

$38.39

0.08 (0.21%)

, GS

Goldman Sachs

$261.52

5.4 (2.11%)

17:03
01/22/18
01/22
17:03
01/22/18
17:03
Hot Stocks
Brinker adds James Katzman To Board of Directors »

Brinker (EAT) announces…

EAT

Brinker

$38.39

0.08 (0.21%)

GS

Goldman Sachs

$261.52

5.4 (2.11%)

HSY

Hershey

$109.96

0.59 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 31

    Jan

  • 01

    Feb

CCXI

ChemoCentryx

$8.31

-0.04 (-0.48%)

17:01
01/22/18
01/22
17:01
01/22/18
17:01
Hot Stocks
ChemoCentryx reports 'positive' survival results from CCX872 trial »

ChemoCentryx announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWHM

New Home Company

$12.89

0.01 (0.08%)

16:58
01/22/18
01/22
16:58
01/22/18
16:58
Syndicate
Breaking Syndicate news story on New Home Company »

New Home Company files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

NWHM

New Home Company

$12.89

0.01 (0.08%)

16:58
01/22/18
01/22
16:58
01/22/18
16:58
Syndicate
Breaking Syndicate news story on New Home Company »

New Home Company files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

TROW

T. Rowe Price

$117.40

0.05 (0.04%)

16:57
01/22/18
01/22
16:57
01/22/18
16:57
Hot Stocks
T. Rowe Price sees FY18 effective tax rate 24%-27% »

On December 22, 2017, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICE

IntercontinentalExchange

$75.83

0.23 (0.30%)

16:45
01/22/18
01/22
16:45
01/22/18
16:45
Hot Stocks
Natixis, NYSE enter licensing agreement »

Natixis Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBIO

Catalyst Biosciences

$21.21

1.72 (8.83%)

16:43
01/22/18
01/22
16:43
01/22/18
16:43
Syndicate
Breaking Syndicate news story on Catalyst Biosciences »

Catalyst Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRET

Investors Real Estate

$5.74

0.03 (0.53%)

16:40
01/22/18
01/22
16:40
01/22/18
16:40
Hot Stocks
Investors Real Estate completes sale of two additional medical office buildings »

IRET completed the sale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFIC

Flushing Financial

$28.93

-0.1 (-0.34%)

16:39
01/22/18
01/22
16:39
01/22/18
16:39
Hot Stocks
Flushing Financial announces dividend plans for 2018 »

Flushing Financia, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

JMBA

Jamba

$9.14

-0.01 (-0.11%)

16:37
01/22/18
01/22
16:37
01/22/18
16:37
Syndicate
Jamba 2.1M share Block Trade; price range $8.25-$8.40 »

Morgan Stanley is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULT

Fulton Financial

$18.65

0.1 (0.54%)

16:37
01/22/18
01/22
16:37
01/22/18
16:37
Earnings
Fulton Financial reports Q4 EPS 19c, consensus 28c »

Net interest income for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

AMGN

Amgen

$192.33

3.05 (1.61%)

16:36
01/22/18
01/22
16:36
01/22/18
16:36
Hot Stocks
Amgen: Aimovig met all primary, secondary endpoints in Phase 3b LIBERTY study »

Amgen announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 03

    Feb

  • 16

    Feb

  • 08

    Mar

  • 25

    Mar

  • 23

    Apr

  • 30

    Apr

  • 17

    May

  • 28

    May

AMGN

Amgen

$192.33

3.05 (1.61%)

16:34
01/22/18
01/22
16:34
01/22/18
16:34
Hot Stocks
Breaking Hot Stocks news story on Amgen »

Amgen: Aimovig met all…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 03

    Feb

  • 16

    Feb

  • 08

    Mar

  • 25

    Mar

  • 23

    Apr

  • 30

    Apr

  • 17

    May

  • 28

    May

FL

Foot Locker

$50.37

0.16 (0.32%)

16:32
01/22/18
01/22
16:32
01/22/18
16:32
Hot Stocks
Foot Locker makes strategic investment in Carbon38 »

Foot Locker announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPE

EP Energy

$2.48

0.17 (7.36%)

16:32
01/22/18
01/22
16:32
01/22/18
16:32
Hot Stocks
EP Energy sees FY18 $600M-$650M of oil and gas expenditures, »

Sees FY18 81…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$98.06

-0.98 (-0.99%)

16:31
01/22/18
01/22
16:31
01/22/18
16:31
Hot Stocks
Darden names Dave George as COO »

Darden Restaurants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAD

Rite Aid

$2.29

-0.02 (-0.87%)

, WBA

Walgreens Boots Alliance

$77.40

0.93 (1.22%)

16:31
01/22/18
01/22
16:31
01/22/18
16:31
Hot Stocks
Rite Aid provides update on sale of assets to Walgreens Boots Alliance »

Rite Aid Corporation…

RAD

Rite Aid

$2.29

-0.02 (-0.87%)

WBA

Walgreens Boots Alliance

$77.40

0.93 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZION

Zions Bancorp

$54.16

0.43 (0.80%)

16:30
01/22/18
01/22
16:30
01/22/18
16:30
Earnings
Zions Bancorp reports Q4 adjusted EPS 80c, consensus 73c »

Harris H. Simmons,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

EPE

EP Energy

$2.48

0.17 (7.36%)

16:30
01/22/18
01/22
16:30
01/22/18
16:30
Hot Stocks
EP Energy reports preliminary FY17 production results of 82,300MBoe/d »

Preliminary FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
01/22/18
01/22
16:30
01/22/18
16:30
Options
Preliminary option volume of 20.3M today »

Preliminary option volume…

RMD

ResMed

$87.51

-1.17 (-1.32%)

16:30
01/22/18
01/22
16:30
01/22/18
16:30
Hot Stocks
Breaking Hot Stocks news story on ResMed »

ResMed up 8.5% to $95.00…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.